Originally designed for oncology products, the Flexi-Cap Protect packaging elements will be showcased at the upcoming Interphex Exhibition (New York, NY, April 26−28). In addition to the cap, which covers the closure and upper part of the container, a second cap is added to protect the bottom and lower part. Both caps are affixed to the container using a label, which can optionally be provided with an integrated foam layer to provide further protection against lateral impact. Consequently, the container’s surface is completely protected.
The product’s original use was for cytostatics, oncology products for which unintentional exposure can have serious health consequences. Another important aspect of Flexi-Cap Protect is that its label and two caps are applied without heat, so that the medicine’s properties are not impaired. In addition, the upper cap offers space for imprinting warning notices, codes for track & trace systems, or integrating NFC inlays for interactive applications.
Like the original Flexi-Cap, Flexi-Cap Protect comprises a film cap positioned over the closed container. The label is applied without covering the peel-open tab of the opening strip. Once the strip is opened, the bottom part of the cap, together with the label, remains attached to the container. Attempting to remove the rest of the cap destroys the label, eliminating the possibility of unnoticed illegal reuse. Flexi-Cap enables flexible use with different container types, forms and sizes.
“Flexi-Cap Protect guards pharmaceutical manufacturers and medical professionals against possible contamination and, in the case of harsh cytostatics, physical harm,” said Gene Dul, president of Schreiner MediPharm US (Blauvelt, NY). “With both benefits, Schreiner MediPharm’s goal is the same: to reliably maintain the integrity of the primary packaging.”